Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Capsule: SOP for Receiving Raw Materials for Capsule Manufacturing – V 2.0

Posted on By

Capsule: SOP for Receiving Raw Materials for Capsule Manufacturing – V 2.0

Standard Operating Procedure for Receiving Raw Materials for Capsule Manufacturing

Department Capsule Manufacturing
SOP No. SOP/CM/001/2025
Supersedes SOP/CM/001/2022
Page No. Page 1 of 10
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

To define the procedure for receiving raw materials used in capsule manufacturing, ensuring they meet quality, safety, and regulatory standards before processing.

2. Scope

Applies to all raw materials, including excipients and APIs, received for capsule manufacturing. Covers inspection, verification, and acceptance/rejection procedures.

3. Responsibilities

  • Warehouse Personnel: Handle offloading, storage, and initial inspection of materials.
  • QC Team: Inspect materials and verify documentation for compliance with specifications.
  • QA Team: Oversee the release of materials and ensure compliance with regulatory standards.
  • Procurement Department: Ensure timely delivery and correct documentation for raw materials.

4. Accountability

The Warehouse Manager ensures the SOP is followed. The QA Manager has final approval over material release and compliance verification.

5. Procedure

5.1 Pre-Arrival Coordination

Before receiving the raw materials, ensure all logistical and documentation steps are prepared:

  1. Confirm delivery dates with the Procurement Department and notify the Warehouse team.
  2. Prepare the receiving area by ensuring it is clean, well-organized, and equipped with necessary tools (e.g.,
scales, temperature monitors).
  • Ensure all personnel are aware of the upcoming delivery to handle materials efficiently.
  • 5.2 Offloading and Documentation Check

    Upon arrival, follow these steps for unloading and verifying documentation:

    1. Inspect the external condition of the shipment for any visible damage (e.g., punctures, tears, leaks).
    2. Check the packing list and Purchase Order (PO) for accuracy, ensuring the number of items matches the shipment.
    3. Verify that all required documents, including the Certificate of Analysis (CoA), Safety Data Sheets (SDS), and batch records, are present and valid.
    4. If discrepancies or damage are found, immediately notify the QA and Procurement team for further investigation.

    5.3 Visual Inspection and Sampling

    Conduct a thorough inspection of the materials and perform sampling as follows:

    1. Check the packaging for any visible signs of tampering, contamination, or damage.
    2. If packaging is damaged, move the material to a designated area and inform QA.
    3. Sample materials based on the approved sampling plan, ensuring all containers are represented.
    4. QC team tests the samples according to predefined specifications (e.g., moisture content, purity, microbial testing).

    5.4 Approval for Storage or Rejection

    Once the inspection and sampling are complete, follow these steps:

    1. If materials pass all inspections and tests, the QA team approves them for storage and production.
    2. Materials are moved to the designated storage area and are labeled as “Approved” for use in capsule manufacturing.
    3. If materials fail to meet the required specifications, they are rejected and moved to the rejection area for further action (e.g., return to vendor).

    5.5 Documentation and Record-Keeping

    Ensure all necessary documentation is completed and maintained for future reference:

    1. Update the Raw Material Receiving Log with details such as material name, batch number, PO number, vendor name, and any discrepancies.
    2. Ensure all documents (e.g., CoA, SDS) are filed appropriately, either physically or electronically.
    3. Document all rejection or non-conformance cases in the Discrepancy Report (Annexure-3), detailing the issue and corrective actions taken.

    5.6 Handling Rejected Materials

    If raw materials are rejected, take the following actions:

    1. Label the materials as “Rejected” and segregate them from the usable stock.
    2. Notify Procurement to initiate a return, replacement, or credit process with the supplier.
    3. Document the rejection in the Discrepancy Report and communicate with the supplier to resolve the issue.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • CoA: Certificate of Analysis
    • SDS: Safety Data Sheet
    • PO: Purchase Order
    • QC: Quality Control
    • QA: Quality Assurance

    7. Documents

    1. Raw Material Receiving Log (Annexure-1)
    2. Certificate of Analysis (CoA) (Annexure-2)
    3. Discrepancy Report (Annexure-3)

    8. References

    • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
    • EU GMP Guidelines Part I – Basic Requirements for Medicinal Products

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Raw Material Receiving Log

    Date Vendor Name Material Name Batch Number Quantity Received PO Number Remarks
    01/02/2025 ABC Suppliers Capsule Material A Batch 12345 500 kg PO-98765 No Damage

    Annexure-2: Certificate of Analysis (CoA)

    Material Batch Number Test Parameter Specification Result Test Date
    Capsule Material A Batch 12345 Purity ≥ 99% 99.5% 01/02/2025

    Annexure-3: Discrepancy Report

    Incident Date Material Name Batch Number Description Corrective Action
    02/02/2025 Capsule Material B Batch 67890 Missing CoA Contacted Vendor for CoA

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP Creation QA Head
    01/02/2025 2.0 Document Format and Updates Standardization QA Head
    See also  Capsule: SOP for Monitoring Hardness of Capsule Shells - V 2.0
    Capsules V 2.0 Tags:Active pharmaceutical ingredients (APIs) Capsule excipients, Capsule batch records, Capsule cleaning procedures, Capsule content uniformity, Capsule deviation management, Capsule disintegration testing, Capsule dissolution testing, Capsule filling process, Capsule inspection techniques, Capsule labeling requirements, Capsule maintenance protocols, Capsule Manufacturing, Capsule manufacturing equipment, Capsule packaging standards, Capsule process validation, Capsule production scheduling, Capsule Quality Control, Capsule regulatory compliance, Capsule safety guidelines, Capsule sealing methods, Capsule size specifications, Capsule stability testing, Capsule storage conditions, Capsule training programs, Empty capsule shells, Hard gelatin capsules, Pharmaceutical capsules, Soft gelatin capsules, Vegetarian capsules

    Post navigation

    Previous Post: Creams: SOP for Dispensing Raw Materials for Cream Formulations – V 2.0
    Next Post: Ointments: SOP for Reviewing Trends in Stability Studies – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version